Healthcare firm secures damages from rival
A Limerick healthcare company will be paid £60,000 in damages and have its legal costs met after a British rival admitted responsibility for defaming the company, a UK court has heard.
In a statement read in open court at the Queen's Bench Division of the English High Court, Limerick-based Nualtra said it had accepted a formal Offer of Amends and agreed terms of settlement with UK-based Aymes International and its founder, Roger Wertheim Aymes.
The settlement in favour of Nualtra ends a long running defamation case brought after a so-called "poison-pen" letter written by an Aymes manager was circulated anonymously to hundreds of doctors in Britain.
Versions of the letter were sent to at least 424 general medical practices, the court heard.
The letter contained a number of spurious allegations against the Irish company's products. The court heard the allegations were wholly without foundation. The defamation case that has now been settled was one of a number of connected legal actions in Ireland and the UK between the two sides.
Founded by dietician Paul Gough in 2012, Nualtra makes nutritional supplements to treat disease-related malnutrition. Its backers include Actavo chief executive Sean Corkery and Leslie Buckley, who are both members of the company's board.
Other board members include former Apple senior VP Dan Byrne and palliative care expert Prof Declan Walsh.